Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?

被引：8
|
作者：
Appel, Gerald B. [1 ]
机构：
[1] Columbia Univ, Med Ctr, Columbia Univ Coll Phys & Surg, Dept Med,Div Nephrol, New York, NY 10032 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 08期
关键词：
THERAPY; ANTIGEN;
D O I：
10.1681/ASN.2012060602
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1280 / 1282
页数：3
相关论文
共 50 条
  • [1] Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?
    Cravedi, Paolo
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 261 - 269
  • [2] Rituximab as first-line treatment of pemphigus
    Schmidt, Enno
    LANCET, 2017, 389 (10083): : 1956 - 1958
  • [3] Treatment with rituximab in idiopathic membranous nephropathy
    Fiorentino, Marco
    Tondolo, Francesco
    Bruno, Francesca
    Infante, Barbara
    Grandaliano, Giuseppe
    Gesualdo, Loreto
    Manno, Carlo
    CLINICAL KIDNEY JOURNAL, 2016, 9 (06) : 788 - 793
  • [4] Rituximab treatment of idiopathic membranous nephropathy
    Fervenza, F. C.
    Cosio, F. G.
    Erickson, S. B.
    Specks, U.
    Herzenberg, A. M.
    Dillon, J. J.
    Leung, N.
    Cohen, I. M.
    Wochos, D. N.
    Bergstralh, E.
    Hladunewich, M.
    Cattran, D. C.
    KIDNEY INTERNATIONAL, 2008, 73 (01) : 117 - 125
  • [5] Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
    Fervenza, F. C.
    Appel, G. B.
    Barbour, S. J.
    Rovin, B. H.
    Lafayette, R. A.
    Aslam, N.
    Jefferson, J. A.
    Gipson, P. E.
    Rizk, D. V.
    Sedor, J. R.
    Simon, J. F.
    McCarthy, E. T.
    Brenchley, P.
    Sethi, S.
    Avila-Casado, C.
    Beanlands, H.
    Lieske, J. C.
    Philibert, D.
    Li, T.
    Thomas, L. F.
    Green, D. F.
    Juncos, L. A.
    Beara-Lasic, L.
    Blumenthal, S. S.
    Sussman, A. N.
    Erickson, S. B.
    Hladunewich, M.
    Canetta, P. A.
    Hebert, L. A.
    Leung, N.
    Radhakrishnan, J.
    Reich, H. N.
    Parikh, S. V.
    Gipson, D. S.
    Lee, D. K.
    da Costa, B. R.
    Juni, P.
    Cattran, D. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 36 - 46
  • [6] Rituximab as a first-line agent for the treatment of dermatomyositis
    Haroon, Muhammad
    Devlin, Joe
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) : 1783 - 1784
  • [7] Rituximab as a first-line agent for the treatment of dermatomyositis
    Muhammad Haroon
    Joe Devlin
    Rheumatology International, 2012, 32 : 1783 - 1784
  • [8] Rituximab in Membranous Nephropathy
    Gauckler, Philipp
    Shin, Jae Il
    Alberici, Federico
    Audard, Vincent
    Bruchfeld, Annette
    Busch, Martin
    Cheung, Chee Kay
    Crnogorac, Matija
    Delbarba, Elisa
    Eller, Kathrin
    Faguer, Stanislas
    Galesic, Kresimir
    Griffin, Sian
    van den Hoogen, Martijn W. F.
    Hruskova, Zdenka
    Jeyabalan, Anushya
    Karras, Alexandre
    King, Catherine
    Kohli, Harbir Singh
    Mayer, Gert
    Maas, Rutger
    Muto, Masahiro
    Moiseev, Sergey
    Odler, Balazs
    Pepper, Ruth J.
    Quintana, Luis F.
    Radhakrishnan, Jai
    Ramachandran, Raja
    Salama, Alan D.
    Schonermarck, Ulf
    Segelmark, Marten
    Smith, Lee
    Tesar, Vladimir
    Wetzels, Jack
    Willcocks, Lisa
    Windpessl, Martin
    Zand, Ladan
    Zonozi, Reza
    Kronbichler, Andreas
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 881 - 893
  • [9] Rituximab in membranous nephropathy
    Ring, Troels
    KIDNEY INTERNATIONAL, 2008, 74 (03) : 391 - 392
  • [10] INTRALESIONAL RITUXIMAB AS A FIRST-LINE TREATMENT IN CUTANEOUS LYMPHOMAS
    Maria, Aspa Cilleruelo Jose
    Garcia Lucia, Castilla
    Charavia Marta, Callejas
    Canete Marta, Gonzalez
    Rodriguez Isabel, Polo
    Ramirez Patricia, Garcia
    Marina Maria, Arguello
    Vazquez Celia, Martinez
    Torres Guzman, Lopez de Hontanar
    Pedro Antonio, Rodriguez Barquero
    Montolvo, Medina
    HAEMATOLOGICA, 2021, 106 (10) : 307 - 307
12345